中东和非洲肝癌诊断市场预测至 2028 年 – COVID-19 影响和分析 – 按类型(实验室测试、内窥镜检查、成像、活检等)和最终用户(医院和诊断实验室、学术和研究)研究所和 CRO 实验室)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 130    |    Report Code: BMIRE00025042    |    Category: Life Sciences

Middle East & Africa Liver Cancer Diagnostics Market

中东和非洲的肝癌诊断市场非洲预计将从 2021 年的 3.8225 亿美元增长到 2028 年的 5.7586 亿美元。预计 2021 年至 2028 年复合年增长率为 6.0%。

 

早期发现和监测肿瘤可以提供更有效的治疗。护理点 (POC) 测试允许患者进行手持式测试,快速给出结果。此外,不需要专业知识或特殊知识,这在资源匮乏地区进行时至关重要。肝细胞癌(HCC)是最常见的恶性肿瘤之一,生存率很低。随着对癌症生物学和技术进步的了解不断加深,我们能够识别出许多驱动肝癌发生的病理、遗传和分子事件,从而发现了这种疾病的许多潜在生物标志物。

 < /p>

用于肝癌的一些生物标志物包括甲胎蛋白 (AFP)、Glypican-3、Des-Gamma-Carboxy(异常)凝血酶原 (DCP)、Gamma-谷氨酰转移酶和血清 Alpha -1-岩藻糖苷酶等。大量生物标志物已被证明具有潜在的预测意义。因此,这一因素将在预计期间为肝癌诊断市场提供巨大机遇。

 

借助新功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动中东和中东地区的发展。非洲肝癌诊断市场在预测期内复合年增长率可观。

 

中东和非洲到2028年非洲肝癌诊断市场收入及预测(百万美元)

 
 

 

中东和中东地区非洲肝癌诊断市场细分

 

中东和非洲根据类型、最终用户和国家对非洲肝癌诊断市场进行分析。根据类型,市场分为实验室测试、成像、内窥镜检查、活检等。 2021年,实验室测试领域占据最大市场份额,成像领域预计在预测期内将实现更高的复合年增长率。

 

根据实验室测试,市场分为血液测试和生物标志物。 2021年,血液检测细分市场占有更大的市场份额,预计该细分市场在预测期内的复合年增长率最高。

 

< p>根据最终用户,市场分为医院和诊断实验室、学术和研究机构以及 CRO 实验室。 2021年,医院和诊断实验室细分市场占据最大市场份额,预计该细分市场在预测期内将实现更高的复合年增长率。

 

基于国家、中东和地区非洲肝癌诊断市场分为沙特阿拉伯、南非、阿联酋和中东和非洲其他地区。 2021年,沙特阿拉伯占据最大的市场份额,预计在预测期内将以最快的复合年增长率增长。

 

雅培;生物梅里埃公司; F. 霍夫曼拉罗什有限公司;照明公司;皇家飞利浦公司;凯杰;西门子医疗股份公司;赛默飞世尔科技有限公司;通用电气医疗保健;和 Perspectum 是中东和非洲地区的领先公司。非洲肝癌诊断市场。




Middle East & Africa Liver Cancer Diagnostics Strategic Insights

Strategic insights for Middle East & Africa Liver Cancer Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-liver-cancer-diagnostics-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Liver Cancer Diagnostics Report Scope

Report Attribute Details
Market size in 2021 US$ 382.25 Million
Market Size by 2028 US$ 575.86 Million
Global CAGR (2021 - 2028) 6.0%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 类型
  • 实验室检查
  • 内窥镜检查
  • 影像学检查
  • 活检
By 最终用户
  • 医院和诊断实验室
  • 学术和研究机构
  • CRO 实验室
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Abbott
  • bioMerieux SA
  • F. HOFFMANN-LA ROCHE LTD.
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • QIAGEN
  • Siemens Healthineers AG
  • THERMO FISHER SCIENTIFIC INC.
  • GE Healthcare
  • Perspectum
  • Get more information on this report

    Middle East & Africa Liver Cancer Diagnostics Regional Insights

    The regional scope of Middle East & Africa Liver Cancer Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-liver-cancer-diagnostics-market-geography.webp
    Get more information on this report

    The List of Companies - Middle East & Africa Liver Cancer Diagnostics Market

    1. Abbott
    2. bioMerieux SA
    3. F. HOFFMANN-LA ROCHE LTD.
    4. Illumina, Inc.
    5. Koninklijke Philips N.V.
    6. QIAGEN
    7. Siemens Healthineers AG
    8. THERMO FISHER SCIENTIFIC INC.
    9. GE Healthcare
    10. Perspectum
    Frequently Asked Questions
    How big is the Middle East & Africa Liver Cancer Diagnostics Market?

    The Middle East & Africa Liver Cancer Diagnostics Market is valued at US$ 382.25 Million in 2021, it is projected to reach US$ 575.86 Million by 2028.

    What is the CAGR for Middle East & Africa Liver Cancer Diagnostics Market by (2021 - 2028)?

    As per our report Middle East & Africa Liver Cancer Diagnostics Market, the market size is valued at US$ 382.25 Million in 2021, projecting it to reach US$ 575.86 Million by 2028. This translates to a CAGR of approximately 6.0% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Liver Cancer Diagnostics Market report typically cover these key segments-

  • 类型 (实验室检查, 内窥镜检查, 影像学检查, 活检)
  • 最终用户 (医院和诊断实验室, 学术和研究机构, CRO 实验室)
  • What is the historic period, base year, and forecast period taken for Middle East & Africa Liver Cancer Diagnostics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Liver Cancer Diagnostics Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Middle East & Africa Liver Cancer Diagnostics Market?

    The Middle East & Africa Liver Cancer Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott
  • bioMerieux SA
  • F. HOFFMANN-LA ROCHE LTD.
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • QIAGEN
  • Siemens Healthineers AG
  • THERMO FISHER SCIENTIFIC INC.
  • GE Healthcare
  • Perspectum
  • Who should buy this report?

    The Middle East & Africa Liver Cancer Diagnostics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Liver Cancer Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.